Browse

S-Space

Browsing by Author Im, Seock-Ah

Jump to a point in the index
Or type in a year

  • Sort by
  • In order
  • Results/Page
  • Authors/record

Showing results 1 to 60 of 114

Issue Date Title / Author(s) / CitationFile
1999
Phase II clinical trial of SKI-2053R, a new platinum analog, in the treatment of patients with advanced gastric adenocarcinoma
DOI
2004
A multi-center, late phase II clinical trial of Genexol (R) (paclitaxel) and cisplatin for patients with advanced gastric cancer
DOI
2004
A combination of HER-2 status and the St. Gallen classification provides useful information on prognosis in lymph node-negative breast carcinoma
link
2005
Epidermal growth factor receptor (EGFR) downstream molecules as response predictive markers for gefitinib (Iressa (R), ZD1839) in chemotherapy-resistant non-small cell lung cancer
link
2005
Predictive and prognostic impact of epidermal growth factor receptor mutation in non-small-cell lung cancer patients treated with gefitinib
DOI
2005
Cytotoxic effects of pemetrexed in gastric cancer cells
link
2005
Reduced dose intensity FOLFOX-4 as first line palliative chemotherapy in elderly patients with advanced colorectal cancer
view fileDOI
2005
Phase II trial of low-dose paclitaxel and cisplatin in patients with advanced gastric cancer
link
2005
Local tumor invasiveness is more predictive of survival than International Prognostic Index in stage I-E/IIE extranodal NK/T-cell lymphoma, nasal type
link
2006
CPR or DNR? End-of-life decision in Korean cancer patients: a single center's experience
link
2006
Antibiotic use during the last days of life in cancer patients
DOI
2006
Optimization of patient selection for gefitinib in non-small cell lung cancer by combined analysis of epidermal growth factor receptor mutation, K-ras mutation, and Akt phosphorylation
DOI
2006
Epidermal growth factor receptor mutations and response to chemotherapy in patients with non-small-cell lung cancer
link
2006
High fluorodeoxyglucose uptake on positron emission tomography in patients with advanced non-small cell lung cancer on platinum-based combination chemotherapy
link
2006
Primary systemic anaplastic large cell lymphoma in a single Korean institution: Clinical characteristics and treatment outcome
view filelink
2006
First-line ifosfamide, methotrexate, etoposide and prednisolone chemotherapy +/- radiotherapy is active in stage I/II extranodal NK/T-cell lymphoma
link
2006
Clinical predictors versus epidermal growth factor receptor mutation in gefitinib-treated non-small-cell lung cancer patients
DOI
2007
Zinc-fingers and homeoboxes 1 (ZHX1) binds DNA methyltransferase (DNMT) 3B to enhance DNMT3B-mediated transcriptional repression
link
2007
Prognostic significance of bcl-2 expression in stage III breast cancer patients who had received doxorubicin and cyclophosphamide followed by paclitaxel as adjuvant chemotherapy
view fileDOI
2007
Intron 1 CA dinucleotide repeat polymorphism and mutations of epidermal growth factor receptor and gefitinib responsiveness in non-small-cell lung cancer
DOI
2007
Artificial nutrition and hydration in terminal cancer patients: the real and the ideal
link
2007
Potential advantages of DNA methyltransferase 1 (DNMT1)-targeted inhibition for cancer therapy
link
2007
Potential advantages of DNA methyltransferase 1 (DNMT1)-targeted inhibition for cancer therapy
link
2007
Phase II study of low-dose paclitaxel and cisplatin as a second-line therapy after 5-fluorouracil/platinum chemotherapy in gastric cancer
view filelink
2007
Prognostic impact of clinicopathologic parameters in stage II/III breast cancer treated with neoadjuvant docetaxel and doxorubicin chemotherapy: paradoxical features of the triple negative breast cancer
view filelink
2008
A phase II trial of S-1 and cisplatin in patients with metastatic or relapsed biliary tract cancer
link
2008
Class II histone deacetylases play pivotal roles in heat shock protein 90-mediated proteasomal degradation of vascular endothelial growth factor receptors
DOI
2008
Metastasis-associated protein S100A4 and p53 predict relapse in curatively resected stage III and IV (M0) gastric cancer
DOI
2008
High tumour islet macrophage infiltration correlates with improved patient survival but not with EGFR mutations, gene copy number or protein expression in resected non-small cell lung cancer
link
2008
Enzastaurin, a protein kinase C beta inhibitor, suppresses signaling through the ribosomal S6 kinase and bad pathways and induces apoptosis in human gastric cancer cells
link
2008
Enzastaurin, a Protein Kinase Cβ Inhibitor, Suppresses Signaling through the Ribosomal S6 Kinase and Bad Pathways and Induces Apoptosis in Human Gastric Cancer Cells
link
2008
Combined lapatinib and cetuximab enhance cytotoxicity against gefitinib-resistant lung cancer cells
link
2008
Weight changes after adjuvant treatment in Korean women with early breast cancer
link
2008
Modified FOLFOX-6 chemotherapy in advanced gastric cancer: Results of phase II study and comprehensive analysis of polymorphisms as a predictive and prognostic marker
view filelink
2008
Aggressiveness of cancer-care near the end-of-life in Korea

Keam, Bhumsuk; Oh, Do-Youn; Lee, Se-Hoon; Kim, Dong-Wan; Kim, Mi Ra; Im, Seock-Ah; Kim, Tae-You; Bang, Yung-Jue; Heo, Dae Seog

Japanese Journal of Clinical Oncology, Vol.38 No.5, pp.381-386

link
2008
A Phase II study of 5-fluorouracil and cisplatin systemic chemotherapy for inoperable hepatocellular carcinoma with α fetoprotein as a predictive and prognostic marker
DOI
2008
ERCC1 expression by immunohistochemistry and EGFR mutations in resected non-small cell lung cancer
DOI
2008
A-kinase anchoring protein 12 regulates the completion of cytokinesis
link
2008
DNA methyltransferase 3B acts as a co-repressor of the human polycomb protein hPc2 to repress fibroblast growth factor receptor 3 transcription
link
2008
Overexpression of A-kinase anchoring protein 12A activates sterol regulatory element binding protein-2 and enhances cholesterol efflux in hepatic cells
link
2008
Mucoepidermoid carcinoma of lung: Potential target of EGFR-directed treatment
DOI
2008
DNA methyltransferase 3B mutant in ICF syndrome interacts non-covalently with SUMO-1
DOI
2008
Irinotecan combined with 5-fluorouracil and leucovorin as second-line chemotherapy for metastatic or relapsed gastric cancer
DOI
2008
The growth inhibitory effect of lapatinib, a dual inhibitor of EGFR and HER2 tyrosine kinase, in gastric cancer cell lines
link
2008
Ongoing debates in the assessment of the HER2 status in breast cancer: A comparative analysis by immunohistochemistry and FISH using original FDA and ASCO/CAP guidelines
DOI
2008
The clinicopathologic characteristics and prognostic significance of triple-negativity in node-negative breast cancer
view filelink
2008
Cancer patients' awareness of clinical trials, perceptions on the benefit and willingness to participate: Korean perspectives
link
2008
Gemcitabine-based versus fluoropyrimidine-based chemotherapy with or without platinum in unresectable biliary tract cancer: a retrospective study
view filelink
2008
Ramosetron for the prevention of nausea and vomiting during 5-fluorouracil-based chemoradiotherapy for pancreatico-biliary cancer
link
2009
Neoadjuvant Chemotherapy Followed by Limited Surgery in a Mouse Model of Head and Neck Cancer
2009
Effective second-line chemotherapy for extranodal NK/T-cell lymphoma consisting of etoposide, ifosfamide, methotrexate, and prednisolone
DOI
2009
Simvastatin plus irinotecan, 5-fluorouracil, and leucovorin (FOLFIRI) as first-line chemotherapy in metastatic colorectal patients: a multicenter phase II study
link
2009
Palliative chemotherapy for patients with recurrent hepatocellular carcinoma after liver transplantation
DOI
2009
Ramosetron for the Prevention of Nausea and Vomiting During 5-Fluorouracil-Based Chemoradiotherapy for Pancreatico-biliary Cancer
DOI
2009
Ki-67 Expression Gives Additional Prognostic Information on St. Gallen 2007 and Adjuvant! Online Risk Categories in Early Breast Cancer
DOI
2009
Weight changes after adjuvant treatment in Korean women with early breast cancer
DOI
2009
The role of PET/CT in detection of gastric cancer recurrence
view fileDOI
2009
Biomarker analysis in stage III-IV (M0) gastric cancer patients who received curative surgery followed by adjuvant 5-fluorouracil and cisplatin chemotherapy: epidermal growth factor receptor (EGFR) associated with favourable survival
DOI
2009
Cost-effectiveness analysis of adjuvant therapy for node positive breast cancer in Korea: docetaxel, doxorubicin and cyclophosphamide (TAC) versus fluorouracil, doxorubicin and cyclophosphamide (FAC)
DOI
2009
Ki-67 Expression Gives Additional Prognostic Information on St. Gallen 2007 and Adjuvant! Online Risk Categories in Early Breast Cancer
DOI
1 2
RSS 1.0 RSS 2.0 Atom

Seoul National University Library, 1 Gwanak-ro, Gwanak-gu, Seoul 08826, Korea TEL: 02-880-5567 Email: s-space@snu.ac.kr

Hello

Browse

News About S-Space Seoul National University Library LOGIN